Atlas Trials

Kidney Function and Risk Factors in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Undergoing 177Lutetium-PSMA Radioligand Therapy: a Prospective Observational Study - KiRi-Trial

Clinical trial NCT06720532 · RECRUITING

Trial details

NCT number
NCT06720532
Sponsor
Hannah Schaefer
Status
RECRUITING
Study type
OBSERVATIONAL
Kidney DiseaseRadiation NephropathyMetastatic Castrate Resistant Prostate Cancer (mCRPC)
Start date
2024-08-05
Primary completion
2027-08-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.